Design and synthesis of novel N-benzylidenesulfonohydrazide inhibitors of murC and murD as potential antibacterial agents

Article abstract of DOI:10.3390/molecules13010011

A series of novel N-benzylidenesulfonohydrazide compounds were designed and synthesized as inhibitors of UDP-N-acetylmuramic acid:L-alanine ligase (MurC) and UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase (MurD) from E. coli, involved in the biosynthes

Full text of DOI:10.3390/molecules13010011

Molecules 2008, 13, 11-30
molecules
ISSN 1420-3049
© 2008 by MDPI
www.mdpi.org/molecules
Full Paper
Design and Synthesis of Novel N-Benzylidenesulfonohydrazide
Inhibitors of MurC and MurD as Potential Antibacterial Agents
Rok Frlan 1, Andreja Kovač 1, Didier Blanot 2, Stanislav Gobec 1, Slavko Pečar 1,3 and Aleš
Obreza 1,*
1
University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, 1000 Ljubljana, Slovenia;
Tel.: (+386) 14769677; Fax: (+386) 14258031
2
Enveloppes Bactériennes et Antibiotiques, IBBMC, UMR 8619 CNRS, Univ Paris-Sud, 91405
Orsay, France
3
“Jožef Stefan” Institute, Jamova 39, 1000 Ljubljana, Slovenia
* Author to whom correspondence should be addressed; e-mail: ales.obreza@ffa.uni-lj.si
Received: 19 November 2007; in revised form: 23 December 2007 / Accepted: 23 December 2007 /
Published: 11 January 2008
Abstract: A series of novel N-benzylidenesulfonohydrazide compounds were designed
and synthesized as inhibitors of UDP-N-acetylmuramic acid:L-alanine ligase (MurC) and
UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase (MurD) from E. coli, involved in
the biosynthesis of bacterial cell-walls. Some compounds possessed inhibitory activity
against both enzymes with IC50 values as low as 30 μM. In addition, a new, one-pot
synthesis of amidobenzaldehydes is reported.
Keywords: MurC, MurD, amidobenzaldehyde, inhibitors, antibacterial, hydrazide.
Introduction
The increasing emergence of pathogenic bacterial strains with high resistance to antibacterial
agents constitutes a serious public health threat. Besides established classes of antimicrobial drugs (β-
lactams, macrolides, and quinolones), drugs considered to be the last line of defence (the glycopeptide

Molecules 2008, 13
12
vancomycin and the oxazolidinone linezolid) are becoming less effective. This serious situation
strongly supports the search for novel antibacterial agents [1-3].
One of the most attractive targets for new antibacterial compounds is the bacterial peptidoglycan
biosynthetic pathway. Peptidoglycan is an essential component of the bacterial cell wall. It is
responsible for a defined cell shape and preserves cell integrity by compensating internal osmotic
pressure. Any perturbation of the multi-step peptidoglycan biosynthesis may lead to cell lysis [4].
Peptidoglycan is formed as a linear chain of repeating N-acetylglucosamine (GlcNAc) and N-acetyl-
muramic acid (MurNAc) units, interconnected by short peptide chains. Four ADP-forming ligases
(MurC, MurD, MurE and MurF) catalyze the assembly of the peptide moiety by the successive
additions of L-alanine, D-glutamate, meso-diaminopimelate (or L-lysine) and D-alanyl-D-alanine to
UDP-MurNAc. These essential cytoplasmic enzymes are highly specific and are present only in
eubacteria, thus making them attractive as targets for the development of new therapeutic agents
against bacterial infections [5].
We were interested in the design, synthesis and biological evaluation of novel inhibitors of MurC
and MurD. MurC (UDP-MurNAc:L-Ala ligase) catalyzes the ATP-dependent ligation of L-alanine and
UDP-MurNAc to form UDP-MurNAc-L-Ala, while MurD (UDP-MurNAc-L-Ala:D-Glu ligase)
catalyzes the addition of D-glutamate to the product of MurC, UDP-MurNAc-L-Ala, to form UDP-
MurNAc-dipeptide (Figure 1) [6].
Figure 1. Reactions catalyzed by MurC and MurD [5,6].
OH
OH
MurC
L-Ala, ATP
O
O
HO
HO
O
O
O
AcHN
AcHN
O-UDP
O-UDP
COOH
HN
HOOC
UDP-MurNAc
OH
UDP-MurNAc-L-Ala
OH
HO
O
MurD
O
HO
O
D-Glu, ATP
O
AcHN
AcHN
O-UDP
O-UDP
HN
O
HN
HOOC
O
O
HN
COOH
COOH
UDP-MurNAc-L-Ala-D-Glu
UDP-MurNAc-L-Ala
Benzylidene rhodanines 1 and 2 (Figure 2), which possess MurC inhibitory activity in the low
micromolar range [7], were used as a starting point for further synthetic modification. They were first
modified on the thioxothiazolidin-4-one ring, which was replaced with an acyclic aryl-substituted
sulfonohydrazone moiety (Figure 3) that still retains the acidic NH group present in rhodanines.
Similar acyclic hydrazones have recently been used by other authors for the synthesis of novel

Molecules 2008, 13
13
antibacterial compounds [8-12]. The p-chlorobenzylthio substituent was then replaced by different
moieties to give the corresponding ethers 5a-i, sulfonates 7a-c, carboxamides 11a-j and carboxylic
ester 14. In this paper, we report the synthesis and biological evaluation of compounds 5a-i, 7a-c, 11a-
j and 14.
Figure 2. Rhodanines 1 and 2 which were used as a starting point for further synthetic modifications.
S
HN
S
S
O
S
S
HN
O
Cl
NO2
1
2
IC50 (MurC)=27
M
IC50 (MurC)=18 M
μ
μ
Figure 3. Design of novel MurC inhibitors.
Ar2
Ar2
SO2
HN
S
Ar1
SO2
HN
HN
S
N
O
N
S
S
O
Cl
Cl
NO2
NO2
5a-i
1
Ar2
Ar2
SO2
HN
Ar2
Ar1
SO2
SO2
HN
O
SO2
HN
N
O
O
N
O
N
HN
Ar1
O
O
7a-c
11a-j
14
Results and Discussion
The compounds with general structure 5a-i were synthesized starting from hydroxybenzaldehydes
3a or 3b, which were treated with the corresponding benzyl halides to yield compounds 4 in high yield
(75-90%), except for 4b (13%). These were then readily coupled with the appropriate
arylsulfonohydrazides [13], to give the corresponding compounds 5a-i in good yield (64-80%) (Figure
4). Sulfonate derivatives 7a-c were synthesized in a similar manner, starting from the

Molecules 2008, 13
14
hydroxybenzaldehyde 3b, which was treated with the appropriate phenylsulfonyl chlorides to give 6a-
c in 57-68% yield, and then coupled with naphthalene-2-sulfonohydrazide hydrochloride to give the
targets 7a-c in 46-80% yield.
Figure 4.
Ar1
Ar1
OH
O
O
i
ii
CHO
CHO
N
NH
Ar2
S
O
3a (2-hydroxy-)
3b (3-hydroxy-)
4a-d
5a-i
O
Ar1
Ar1
O S O
O
O
S O
iv
O
CHO
iii
N
NH
Ar2
O
S
6a-c
7a-c
O
Reaction conditions: i) Ar1CH2Cl, KF, K2CO3, THF or Ar1CH2Br, K2CO3, acetone, ii)
Ar2SO2NHNH3Cl, K2CO3, EtOH, iii) Ar1SO2Cl, K2CO3, THF, iv) Ar2SO2NHNH3Cl, K2CO3,
THF.
The synthetic route selected for the preparation of inhibitors 11a-j (Figure 5) involved the
protection of para- (8a) and ortho- (8b) nitrobenzaldehydes as dioxolanes 9a and 9b, which should be
deprotectable under mild acidic conditions. The reduction of dioxolanes 9a and 9b led to unstable 1,3-
dioxolan-2-yl anilines 15, that are prone to form polymers, in a manner similar to that reported for p-
nitrobenzyl esters by Wakselman and Guibé-Jampel [14]. Different reducing agents (SnCl2, Zn dust,
sodium sulphides, catalytic hydrogenation) and solvents (water, acetic acid, methanol, THF) were
tried, but the polymerization process (seen as the formation of an orange solid) started immediately
and was enhanced by the presence of water, acid, or by heating (Figure 6). The optimal method for
reducing 9a or 9b was therefore catalytic hydrogenation in anhydrous THF (2 h, Pd/C as a catalyst,
r.t., 5 bar). The product was immediately (without isolation and purification of 15a-b) treated with
suitable benzoyl chlorides to give the corresponding amides with simultaneous deprotection of the
formyl group. Purification of the crude product by column chromatography yielded
amidobenzaldehydes 10a-j in moderate yields for most of the compounds. The condensation of
aldehydes 10a-j with 2-naphthalene-sulfonohydrazide hydrochloride afforded compounds 11a-j. The
method described in this article was appropriate only for the synthesis of amidobenzaldehydes. When
sulfonyl chlorides were used as reagents instead of benzoyl chlorides (i.e. for the synthesis of
sulfonamidobenzaldehydes) only the polymerization reaction occurred.
Our synthetic pathway presents a significant improvement in terms of reaction time, cost of
reagents and overall yield, when compared to the previously reported synthesis of benzamides (related
to 10) with potassium selenocarboxylates via azides [15]. In 2001, the synthesis of 15a from 9a by
catalytic hydrogenation was described, however without mention of the polymerization reaction [16].

Molecules 2008, 13
15
Figure 5.
Ar1
Ar1
HN
O
NO2
NO2
HN
O
O
O
N NH
i
iv
ii, iii
Ar2
CHO
CHO
S
O
O
8a (4-nitro-)
8b (2-nitro-)
9a (4-nitro-)
9b (2-nitro-)
11a-j
10a-j
Reaction
conditions:
i)
Ethyleneglycol, pTsOH, toluene, ii) H2/Pd/C, THF, iii) Ar1COCl, K2CO3, THF, iv)
Ar2SO2NHNH3Cl, K2CO3, CH2Cl2.
Figure 6. Mechanism proposed for the beginning of polymerization of 2-nitrophenyl-1,3-
dioxolane during reduction.
NH
NH2
NO2
cat. water, acid
or heating
polymerization
or
H2/Pd/C
NH
OH
16b
O
O
O
O
OH
9a (4-nitro-)
9b (2-nitro-)
15a-b
16a
We also tried to prepare carboxylic ester derivatives in a manner analogous to the preparation of
ethers 5a-i and sulfonates 7a-c. Virtually all efforts failed at the last step (i.e. condensation with 2-
naphthylsulfonohydrazide). We suspect that these aromatic esters hydrolyzed to alcohols and
carboxylic acids due to our inability to remove water completely from the reaction mixture during the
condensation. Therefore, only compound 14 was synthesized via the acylation of salicylaldehyde with
activated 2-(1,3-benzodioxol-5-yl)acetic acid and subsequent condensation of the ester with 2-
naphthylsulfonhydrazide (Figure 7).
Figure 7.
O
O
O
O
O
O
O
i, ii
iii
O
O
O
H
O
N
OH
O
N
S
Ar2
13
14
12
O
O
Reaction conditions: i) ClOC-COCl, DMF(cat.), CH2Cl2, ii) salicylaldehyde, Et3N, CH2Cl2, iii)
Ar2SO2NHNH3Cl, K2CO3, THF.

Molecules 2008, 13
16
Biological Activity
Results of the in vitro testing of compounds 5a-i, 7a-c, 11a-j and 14 for inhibitory activity against
MurC and MurD are presented in Table 1. They are given as residual activities (RA) of the enzyme in
the presence of a 100-µM (or less in the case of low solubility) concentration of inhibitory compound.
Table 1: In vitro inhibitory activity against MurC and MurD.
Ar1
Ar1
Ar1
S
O
O
O
O
O
HN
O
O
O
O
H
N
NH
O
N
NH
N NH
N
N
S
S
Ar2
S Ar2
S
Ar2
Ar2
O
O
O
O
O
O
O
14
5a-5i
11a-11j
7a-7c
MurC
RA% a
MurD
position on
ring
Compds
5a
Ar1
Ar2
b
b
IC50
RA% a
IC50
36c
62 µM
70 µM
NC
2
2
NO2
5b
30c
65d
58d
95c
nd
O2N
O2N
5c
5d
5e
5f
2
3
2
2
70d
61d
86c
74c
NO2
NC
NC
O2N
5g
5h
5i
2
2
2
100c
59c
nd
58c
39c
57c
NC
NC
NC
F
CF3
NO2
7a
2
55d
71d
70d
O2N
O2N
7b
7c
2
2
65d
75c
74 µM

Molecules 2008, 13
17
Table 1. Cont.
11a
4
4
97c
56c
78c
78d
O2N
11b
72c
91d
O2N
NC
11c
4
4
4
4
NO2
11d
51 µM
30 µM
45 µM
71d
41c
81d
O2N
11e
Br
11f
30 µM
55 µM
Br
11g
4
4
11h
31 µM
27 µM
19e
O2N
11i
2
51c
49 µM
43 µM
O2N
O2N
11j
2
2
O
O
14
57c
49c
a
Data are the means of duplicate determinations. Standard deviations
were within 10% of the values shown.
b
Calculated from the fitted regression equation using the logit-log plot.
Standard deviations at 95% of confidence were within 20% of the
values shown.
at 100 μM
at 50 μM
c
d
e
at 10 μM
nd: not determined
IC50 values were determined for the most active compounds. Several compounds possessed
inhibitory activity against both ligases MurC and MurD, with the amide series (especially compounds
11f, 11h and 11j) being the most potent low-molecular-weight dual inhibitors of both enzymes
reported to date. Lipophilic substituents such as halogens, cyano, nitro and methoxy are preferred on
the distal phenyl ring and significantly enhance the activity when compared with compound 11a.
Interestingly, the transformation of amide 11j to sulfonate 7c resulted in a significant decrease of
inhibitory activity against MurC and in a moderate reduction of inhibitory activity against MurD. In
the series of phenylbenzyl ethers not only Ar1 was changed, but also Ar2, in order to gain compounds
5a-i, which are almost equally potent against both enzymes. Compounds 5a and 5b are the most potent

Molecules 2008, 13
18
inhibitors of MurD from this series. In general, the series of phenylbenzyl ethers had slightly weaker
inhibitory activity against MurC and MurD than the amide series. In addition, with exception of 5h,
the use of different Ar2 moieties resulted in lower activity against both enzymes when compared with
the analogue with a naphthalene ring, 5a. The optimal distance between the two phenyl rings was
established to be two atoms. However, ester 14, which has an additional methylene group, was also
active. During the determination of IC50 values of compounds presented in this paper we noted that
some inhibitors displayed high Hill coefficients [17]. Due to this inhibitory characteristic and the
lipophilic properties of our inhibitors, there is the possibility that some of these compounds act as non-
specific binders.
Conclusions
In summary, we have described the synthesis and structure-activity relationship of a series of novel
N’-benzylidenesulfonohydrazides as inhibitors of MurC and MurD and as potential lead compounds
for the development of new antibacterial drugs. In addition, we report a new, rapid and efficient one-
pot synthesis of amidobenzaldehydes. The amide series provided the most potent dual inhibitors of
both MurC and MurD ligases. Replacement of the amide functionality with an ester or benzylether
group decreased the activity of compounds. Despite the fact that the series of phenylbenzyl ethers were
slightly less active, they served as an indicator that inhibitory activity can be further enhanced with
proper tuning of the Ar1 and Ar2 substituents. Further optimization of the reported inhibitors and in
vitro determination of their MurC and MurD inhibitory activities are in progress and will be reported
in due course.
Experimental
General
Chemicals from Fluka and Sigma-Aldrich Chemical Co. were used without further purification.
Anhydrous tetrahydrofuran and Et3N were dried and purified by distillation over Na and KOH,
respectively. Analytical thin-layer chromatography (TLC) was performed on Merck silica gel (60F254)
plates (0.25 mm). Column chromatography was performed on silica gel 60 (Merck, particle size 240-
400 mesh). Melting points were determined on a Reichert hot stage microscope and are uncorrected.
13
1H- and C-NMR spectra were recorded at 300 and 75 MHz, respectively, on a Bruker AVANCE
DPX300 spectrometer in DMSO-d6 solutions, unless otherwise indicated, with TMS as internal
standard. Chemical shifts were reported in ppm (δ) downfield from TMS. All the coupling constants
(J) are in hertz. IR spectra were recorded on a Perkin-Elmer FTIR 1600 spectrometer. Mass spectra
were obtained with a VG-Analytical Autospec Q mass spectrometer with EI or FAB ionization (MS
Centre, Jožef Stefan Institute, Ljubljana). Elemental analyses were performed by the Department of
Organic Chemistry, Faculty of Chemistry and Chemical Technology, Ljubljana, on a Perkin Elmer
elemental analyzer 240 C. All reported yields correspond to yields of purified products.

Molecules 2008, 13
19
Synthesis of 4-[(2-formylphenoxy)methyl]benzonitrile (4a) [18]
K2CO3 (2.00 g, 14.47 mmol) was added to a solution of salicylaldehyde (1.33 g, 10.89 mmol) and
4-bromomethyl(benzonitrile) (2.13 g, 10.87 mmol) in acetone (50 mL) and the mixture was heated
under reflux for 12 hours. The solvent was removed under reduced pressure and the residue was taken
up in ethyl acetate (100 mL), washed with 10% citric acid (2×20 mL), saturated NaHCO3 (2×20 mL)
and brine (20 mL), and dried over Na2SO4. After filtration and evaporation of the solvent in vacuo the
crude 4-((2-formylphenoxy)methyl)benzonitrile (4a) was purified by recrystallization from diethyl
1
ether (Et2O, 1.95 g, 76%); colourless solid; m.p. 99-100 °C; H-NMR (CDCl3): δ 5.19 (s, 2H, Ar-
CH2), 7.22-7.28 (m, 1H, Ar-H), 7.44-7.52 (m, 3H, Ar-H), 7.55-7.71 (AA’BB’, J = 8.5 Hz, Δν = 40.5
Hz, 4H, Ar-H), 9.98 (s, 1H, Ar-CHO) ppm; MS (FAB+) m/z (%): 237 (MH+, 49), 116 (100). IR (KBr):
ν 2223, 1692, 1598, 1484, 1395, 1264, 1166, 1049, 866, 783, 680, 543 cm-1; Anal. calc. for
C15H11NO2: C 75.94, H 4.67, N 5.90%. Found: C 75.99, H 4.46, N 5.86%.
General procedure for the synthesis of 2-(arylmethyloxy)benzaldehydes 4b-d
To a solution of the corresponding arylmethyl chloride (1 mmol) and salicylaldehyde (1 mmol) in
THF (5 mL), triethylamine (1.25 mmol) and KF (2 mmol) were added with stirring and the mixture
was refluxed under argon for 12 hours. The solvent was removed under reduced pressure. The residue
was taken up in ethyl acetate (25 mL), washed sucessively with 10% citric acid (2×5 mL), saturated
NaHCO3 (2×5 mL) and brine (5 mL), and dried over Na2SO4. After filtration and evaporation of the
solvent in vacuo the crude product was purified by column chromatography or recrystallization, as
indicated.
2-(2-Nitrobenzyloxy)benzaldehyde (4b). Yield 13%; colourless solid; recrystallization from Et2O; m.p.
1
103-105 °C; H-NMR: δ 5.45 (s, 2H, Ar-CH2), 7.09-7.17 (m, 1H, Ar-H), 7.30-7.37 (m, 1H, Ar-H),
7.64-7.72 (m, 1H, Ar-H), 7.72-7.78 (m, 2H, Ar-H), 7.97-8.05 (m, 1H, Ar-H), 8.18-8.25 (m, 1H, Ar-H),
8.40 (s, 1H, Ar-H), 10.45 (s, 1H, Ar-CHO) ppm; MS (FAB+) m/z (%): 258 (MH+, 33), 136 (100); IR
(KBr): ν 3452, 1679, 1599, 1528, 1461, 1350, 1238, 1025, 802, 730 cm-1; Anal. calc. for C14H11NO4: C
65.37, H 4.31, N 5.44%. Found: C 64.99, H 4.16, N 5.46 %.
3-(3-Nitrobenzyloxy)benzaldehyde (4c) [19]. Yield 90%; yellow solid; recrystallization from Et2O;
1
m.p. 112-115 °C; H-NMR (CDCl3): δ 5.25 (s, 2H, Ar-CH2), 7.25-7.34 (m, 1H, Ar-H), 7.46-7.56 (m,
3H, Ar-H), 7.57-7.66 (m, 1H, Ar-H), 7.76-7.84 (m, 1H, Ar-H), 8.19-8.26 (m, 1H, Ar-H), 8.26 (s, 1H,
Ar-H), 10.01 (s, 1H, Ar-CHO) ppm; MS (EI) m/z (%): 257 (M+, 20), 136 (100); IR (KBr): ν 2940,
2837, 1637, 1594, 1454, 1264, 1152, 1039, 784.
2-(3-Nitrobenzyloxy)benzaldehyde (4d). Yield 87%; Rf 0.15 (hexane-ethyl acetate = 4:1); m.p. 120-
1
122 °C; H-NMR: δ 5.45 (s, 2H, Ar-CH2), 7.09-7.17 (m, 1H, Ar-H), 7.30-7.37 (m, 1H, Ar-H), 7.63-
7.79 (m, 3H, Ar-H), 7.98-8.04 (m, 1H, Ar-H), 8.18-8.25 (m, 1H, Ar-H), 8.40 (s, 1H, Ar-H), 10.45 (s,
1H, Ar-CHO) ppm; MS (EI) m/z (%): 257 (M+, 10), 136 (100); IR (KBr): ν 3452, 1679, 1599, 1528,

Molecules 2008, 13
20
1461, 1350, 1238, 1025, 802, 730 cm-1; Anal. calc. for C14H11NO4: C 65.37,H 4.31, N 5.44%. Found:
C 65.15, H 4.46, N 5.47%.
General procedure for the synthesis of 2-formylphenyl benzenesulfonate derivatives 6a-c
To a solution of salicylaldehyde (1 mmol) and Et3N (1.5 mmol) in THF (1 mL) an appropriate
benzenesulfonyl chloride derivative (1 mmol) was added at 0 °C. The solution was stirred for 12 hours
at room temperature. The solvent was removed under reduced pressure. The residue was taken up in
ethyl acetate (25 mL), washed with 10% citric acid (2×5 mL), saturated NaHCO3 (2×5 mL) and brine
(5 mL), and dried over Na2SO4. After filtration and evaporation of solvent in vacuo the crude product
was purified by recrystallization from Et2O.
1
2-Formylphenyl 2-nitrobenzenesulfonate (6a). Yield 57%; yellow solid; m.p. 85-86 °C. H-NMR
(CDCl3): δ 7.21-7.28 (m, 1H, Ar-H), 7.44-7.52 (m, 1H, Ar-H), 7.60-7.67 (m, 1H, Ar-H), 7.8-7.9 (m,
1H, Ar-H), 7.88-7.95 (m, 1H, Ar-H), 8.20-8.27 (m, 1H, Ar-H), 8.54-8.61 (m, 1H, Ar-H), 8.71-8.76 (m,
1H, Ar-H), 10.1 (s, 1H, Ar-CHO) ppm; 13C-NMR DEPT 135: 187.5, 151.1, 149.1, 138.7, 135.9, 130.1,
129.5, 128.8, 128.4, 124.9, 123.3 ppm; MS (FAB+): m/z (%): 308 (MH+, 14), 55 (100). IR (KBr): ν
3093, 1694, 1603, 1532, 1350, 1202, 1065, 860, 717, 628, 554 cm-1; Anal. calc. for C13H9NO6S: C
50.81, H 2.95, N 4.56%. Found: C 50.98, H 3.01, N 4.58 %.
1
2-Formylphenyl 3-nitrobenzenesulfonate (6b). Yield 57%; yellow solid; m.p. 103-104 °C. H-NMR
(CDCl3): δ 7.35-7.41 (d, J1 = 8.0 Hz, 1H, Ar-H), 7.45-7.53 (dd, J1 = 7.5 Hz, J2 = 7.5 Hz 1H, Ar-H),
7.61-7.70 (m, 1H, Ar-H), 7.66-7.82 (m, 1H, Ar-H), 7.88-7.93 (m, 2H, Ar-H), 7.93-7.99 (dd, J1 = 7.5
Hz, J2 = 2.0 Hz, 1H, Ar-H), 7.99-8.05 (d, J = 7.5 Hz, 1H, Ar-H), 10.25 (s, 1H, Ar-CHO) ppm; MS
(FAB+): m/z (%): 308 (MH+, 22), 55 (100). IR (KBr): ν 3100, 2884, 2765, 1702, 1604, 1542, 13 80,
1194, 1086, 873, 785, 588 cm-1; Anal. calc. for C13H9NO6S: C 50.81, H 2.95, N 4.56%. Found: C
50.90, H 3.10, N 4.45 %.
1
2-Formylphenyl 4-nitrobenzenesulfonate (6c). [20] Yield 68%; yellow solid; m.p. 117-119 °C. H-
NMR (CDCl3): δ 7.20 (dd, J1 = 8.0 Hz, J2 = 1.0 Hz, 1H, Ar-H), 7.45-7.54 (dd, J1 = 7.5 Hz, J2 = 7.5 Hz,
1H, Ar-H), 7.60-7.69 (m, 1H, Ar-H), 7.91-7.97 (dd, J1 = 7.5 Hz, J2 = 2.0 Hz, 1H, Ar-H), 8.10-8.40
(AA’XX’, J = 9.0 Hz, Δν = 90 Hz; 4H, Ar-H), 10.09 (s, 1H, Ar-CHO) ppm; MS (FAB+): m/z (%): 308
(MH+, 100). IR (KBr): ν 3104, 2869, 1694, 1597, 1531, 1381, 1192, 1089, 899, 804, 603 cm-1; Anal.
calc. for C13H9NO6S: H 2.95, C 50.81, N 4.56%. Found: H 3.01, C 50.98, N 4.58 %. Anal. calc. for
C13H9NO6S: C 50.81, H 2.95, N 4.56%. Found: C 50.71, H 3.02, N 4.76 %.
General procedure for the synthesis of 2-(nitrophenyl)-1,3-dioxolanes 9a and 9b
The corresponding nitrophenyl-1,3-dioxolanes 9a and 9b were prepared by a reported method [16].
Suitable nitrobenzaldehyde (5.76 g, 38.1 mmol), 4-toluenesulfonic acid monohydrate (0.24 g, 1.26
mmol) and ethylene glycol (13.2 g, 213 mmol) were dissolved in toluene (40 mL). After the addition
of ground 4 Å molecular sieves (1.00 g) the solution was refluxed for 6 hours. After cooling, the

Molecules 2008, 13
21
mixture was partitioned between toluene and distilled water (50 mL) and the aqueous layer extracted
again with toluene (2×20 mL) and ethyl acetate (30 mL). The combined organic layers were washed
with brine (40 mL), dried over Na2SO4, and the solvent removed in vacuo.
2-(4-Nitrophenyl)-1,3-dioxolane (9a) [16] Yield 90%; yellow solid; m.p. 65-68 °C; 1H-NMR (CDCl3):
δ 4.09 (m, 4H, O-CH2-CH2-O), 5.89 (s, 1H, CH), 7.64-8.25 (AA’XX’, J = 9.0 Hz, Δν = 174.0 Hz, 4H,
Ar-H) ppm; MS (FAB+) m/z (%): 196 (MH+, 83), 154 (100); IR (KBr): ν 2896, 1709, 1612, 1523,
1355, 1218, 1079, 848, 750, 697 cm-1.
1
2-(2-Nitrophenyl)-1,3-dioxolane (9b). [21] Yield 91%; yellow oil; H-NMR (CDCl3): δ 4.04 (m, 4H,
O-CH2-CH2-O), 6.48 (s, 1H, CH), 7.50 (m, 1H, Ar-H), 7.62 (m, 1H, Ar-H), 7.80 (d, 1H, J = 8.0 Hz,
Ar-H), 7.89 (d, 1H, J = 8.0 Hz, Ar-H) ppm; MS (EI) m/z (%): 195 (M+, 69), 148 (100); IR (KBr): ν
2893, 1704, 1530, 1350, 1198, 1108, 944, 788 cm-1.
General procedure for the synthesis of N-(formylphenyl)benzamide derivatives 10a-j
The corresponding 2-(nitrophenyl)-1,3-dioxolanes 9a or 9b (2.00 g, 10.2 mmol) were dissolved in
anhydrous THF (50 mL) and Pd/C (200 mg) was added. The resulting solution was hydrogenated in a
Parr apparatus at 5 bar for 2 hours, filtered and immediately used for further reaction. The appropriate
benzoyl chloride derivative (10.2 mmol) and K2CO3 (10.2 mmol) were then added and the mixture was
stirred for 3 hours. The solvent was removed under reduced pressure. The residue was taken up in
ethyl acetate (100 mL), washed with 10% citric acid (2×20 mL), saturated NaHCO3 (2×20 mL) and
brine (20 mL) and dried over Na2SO4. After filtration and evaporation of the solvent in vacuo the
crude product was purified by column chromatography or by recrystallization from Et2O, as indicated.
N-(4-Formylphenyl)benzamide (10a). [22] Yield 78%; yellow solid; recrystallized; m.p. 121-123 °C;
1H-NMR: δ 7.54 – 7.66 (m, 3H, Ar-H), 7.92-8.04 (AA’BB’, J = 8.5 Hz, Δν = 37.0 Hz, 4H, Ar-H), 7.98
(m, 2H, Ar-H), 9.92 (s, 1H, CHO), 10.64 (s, 1H, NH-CO) ppm; MS (EI) m/z (%): 225 (M+, 27), 105
(100); IR (KBr): ν 3336, 2737, 1696, 1659, 1592, 1524, 1415, 1323, 1168, 826, 718 cm-1; HR-MS
(FAB+): Calc. for C14H11NO2: 225.078979. Found: 225.079580.
N-(4-Formylphenyl)-3,5-dinitrobenzamide (10b). Yield 80%; yellow solid; recrystallized; m.p. 258-
264 °C; 1H-NMR: δ 7.97 (AA’BB’, J = 8.0 Hz, Δν = 24.0 Hz, 4H, Ar-H), 9.02 (t, 1H, J = 3.5 Hz, Ar-
H), 9.19 (m, 2H, Ar-H), 9.96 (s, 1H, CHO), 11.20 (s, 1H, NH-CO) ppm; MS (EI) m/z (%): 315 (M+,
73), 195 (100); Anal. calc. for C14H9N3O5 × 1/3 H2O: C 52.34, H 3.03, N 13.08 %, Found: C 52.62, H
3.06, N 12.83 %.
4-Cyano-N-(4-formylphenyl)benzamide (10c). Yield 75%; yellow solid; recrystallized; m.p. 189-192
°C; 1H-NMR: δ 7.90-8.04 (AA’BB’, J = 9.0 Hz, Δν = 26.4 Hz, 4H, Ar-H), 8.05-8.16 (m, 4H, Ar-H),
9.93 (s, 1H, CHO), 10.84 (s, 1H, NH-CO) ppm; MS (EI) m/z (%): 250 (M+, 37), 130 (100); IR (KBr):
ν 3350, 2228, 1677, 1591, 1532, 1323, 1166, 832, 757 cm-1; HR-MS (FAB+): Calc. for C15H10N2O2:
250.074228. Found: 250.075050.

Molecules 2008, 13
22
N-(4-Formylphenyl)-2-nitrobenzamide (10d). Yield 55%; yellow solid; purified by chromatography,
Rf = 0.00 (hexane-dichloromethane = 1:3), then the product was eluated with methanol; m.p. 128-130
°C; 1H-NMR: δ 7.80–7.83 (m, 2H, Ar-H), 7.88–7.95 (m, 5H, Ar-H), 8.19 (m, 1H, Ar-H), 9.93 (s, 1H,
CHO), 11.09 (s, 1H, NH-CO) ppm; MS (EI) m/z (%): 270 (M+, 85), 150 (100).; IR (KBr): ν 3333,
1682, 1596, 1524, 1347, 1255, 1164, 897, 834, 705 cm-1; HR-MS (FAB+): Calc. for C14H10N2O4.
270.064057. Found: 270.064850.
N-(4-Formylphenyl)-4-nitrobenzamide (10e). Yield 43%; yellow solid; recrytallized; m.p. 213-216 °C;
1H-NMR: δ 7.90–8.02 (AA’BB’, J = 8.5 Hz, Δν = 32.5 Hz, 4H, Ar-H), 8.22-8.35 (AA’BB’, J = 8.5
Hz, Δν = 39.5 Hz, 4H, Ar-H), 9.92 (s, 1H, CHO) ppm; MS (EI) m/z (%): 270 (M+, 36), 150 (100). IR
(KBr): ν 3362, 1674, 1590, 1578, 1319, 1172, 830, 710 cm-1; HR-MS (FAB+): Calc. for C14H10N2O4:
270.064057. Found: 270.064860
3-Bromo-N-(4-formylphenyl)benzamide (10f). Yield 94%; yellow solid; recrystallized; m.p. 163-165
°C; 1H-NMR: δ 7.53 (m, 1H, Ar-H), 7.83 (m, 1H, Ar-H), 7.91–8.04 (m, 5H, Ar-H), 8.17 (s, 1H, Ar-H),
9.93 (s, 1H, CHO), 10.73 (s, 1H, NH-CO) ppm; MS (EI) m/z (%): 303/305 (M+, 24), 183/185 (100);
IR (KBr): ν 3357, 1679, 1587, 1533, 1325, 1165, 838, 710 cm-1; HR-MS (FAB+): Calc. for
C14H10BrNO2. 302.989490. Found: 302.988320.
2-bromo-N-(4-formylphenyl)benzamide (10g). Yield 80%; yellow solid; recrystallized; m.p. 118-120
oC; 1H-NMR: δ 7.43–7.55 (m, 3H, Ar-H), 7.61 (m, 1H, Ar-H), 7.75 (m, 1H, Ar-H), 7.90–7.97 (m, 3H,
Ar-H), 9.93 (s, 1H, CHO), 10.92 (s, 1H, NH-CO) ppm; MS (EI) m/z (%): 303/305 (M+, 17), 183/185
(100); IR (KBr): ν 3247, 1689, 1596, 1530, 1330, 1165, 1026, 896, 833, 744 cm-1; HR-MS (FAB+):
Calc. for C14H10BrNO2: 302.989490. Found: 302.990210.
N-(4-formylphenyl)2-naphthamide (10h). Yield 60%; yellow solid; recrystallized; m.p. 135-137 °C;
1H-NMR: δ 7.66 (m, 2H, Ar-H), 7.95-8.07 (m, 8H, Ar-H), 8.61 (s, 1H, Ar-H), 9.94 (s, 1H, CHO),
10.80 (s, 1H, NH-CO) ppm; MS (EI) m/z (%): 275 (M+, 87), 155 (100); IR (KBr): ν 3371, 1697, 1664,
1560, 1526, 1413, 1322, 1168, 828, 758, 606 cm-1; HR-MS (FAB+): Calc. for C18H13NO2: 275.094629.
Found: 275.095240.
1
N-(2-formylphenyl)-3,5-dinitrobenzamide (10i). Yield 52%; yellow solid; m.p. 258-260 °C; H-NMR:
δ 7.48 (dd, 1H, J1 = J2 = 7.5 Hz, Ar-H), 7.80 (m, 1H, Ar-H), 7.97 (dd, 1H, J1 = 7.5 Hz, J2 = 1.5 Hz, Ar-
H), 8.10 (m, 1H, Ar-H), 9.05 (t, 1H, J = 2.0 Hz, Ar-H), 9.16 (m, 2H, Ar-H), 10.12 (s, 1H, CHO), 11.72
(s, 1H, NH-CO) ppm; MS (EI) m/z (%): 315 (M+, 49), 287 (100); IR (KBr): ν 3086, 1690, 1531, 1343,
1195, 907, 783, 712 cm-1; Anal. calc. for C14H9N3O5 × 1/2 H2O: C 51.86, H 3.11, N 12.96 %; Found:
C 51.93, H 2.84, N 12.94 %.
N-(2-formylphenyl)-4-nitrobenzamide (10j). Yield 25%; yellow solid; recrystallized; m.p. 233-237 °C;
1H-NMR: δ 7.34 (dd, 1H, J1 = J2 = 7.5 Hz, Ar-H), 7.75 (dd, J1 = J2 = 8.0 Hz, Ar-H), 7.97 (dd, 1H, J1 =
7.5 Hz, J2 = 1.5 Hz, Ar-H), 8.10 (d, 1H, J = 8.0 Hz, Ar-H), 8.20-8.33 (AA’BB’, J = 8.5 Hz, Δν = 39.5
Hz, 4H, Ar-H); MS (EI) m/z (%): 270 (M+, 42), 105 (100); IR (KBr): ν 3314, 1647, 1542, 1450, 1307,

Molecules 2008, 13
23
1126, 947, 734 cm-1; Anal. calc. for C14H10N2O4: C 62.22, H 3.73, N 10.37%; Found: C 62.15, H 3.92,
N 10.21 %.
Synthesis of 2-formylphenyl 2-(benzo[d][1,3]dioxol-5-yl)acetate (13)
To a solution of 2-(benzo[d][1,3]dioxol-5-yl)acetic acid (448 mg, 2.49 mmol) in dry
dichloromethane (10 mL) one drop of dry DMF was added with stirring. Oxalyl chloride (0.40 mL, 4.7
mmol) was then added dropwise at 0 °C. The mixture was stirred on an ice-bath for 20 minutes and for
a further hour at room temperature. The solvent was evaporated and the crude product dissolved in
dichloromethane (5 mL) and added dropwise to a solution of salicylaldehyde (7b, 300 mg, 2.46 mmol)
and triethylamine (0.4 mL, 2.9 mmol) in dichloromethane (10 mL). After 3 hours, more
dichloromethane (50 mL) was added. The resulting solution was washed thoroughly with 10% citric
acid (2×20 mL), saturated NaHCO3 (2×20 mL) and brine (20 mL) and then dried over Na2SO4. After
filtration and evaporation of the solvent in vacuo, the crude product was purified by column
1
chromatography. Yield 73%; Rf = 0.25 (hexane-ethyl acetate = 1:1); H-NMR (300 MHz, CDCl3): δ
3.90 (s, 2H, CH2COO), 5.99 (s, 2H, OCH2O), 6.80-6.95 (m, 3H, Ar-H), 7.15-7.21 (d, J = 8.0 Hz, 1H,
Ar-H), 7.37-7.45 (dd, J1 = 7.5 Hz, J2 = 7.5 Hz, 1H, Ar-H), 7.59-7.67 (dd, J1 = 8.0 Hz, J2 = 7.5 Hz, 1H,
Ar-H), 7.85-7.92 (m, 1H, Ar-H), 10.01 (s, 1H, Ar-CHO) ppm; MS (FAB+) m/z (%): 284 (MH+, 48),
162 (100); IR (KBr): 1763, 1697, 1605, 1488, 1252, 1123, 1033, 924, 775 cm-1; HR-MS (FAB+): Calc.
for C16H12O5: 284.068474. Found: 284.069230.
General procedure for the synthesis of N-benzylidenesulfonohydrazide derivatives 5a-i, 7a-c, 11a-j
and 14.
To a solution of the corresponding aldehydes 4a-d, 6a-c, 10a-j or 13 (1 mmol) in dry THF or
absolute ethanol (25 mL), K2CO3 (1 mmol) and aryl-2-sulfonohydrazide hydrochloride (1 mmol) were
added and the mixture stirred under argon for 24 hours. The solvent was removed under reduced
pressure. The resulting crude residue was taken up in ethyl acetate (100 mL), washed with 10% citric
acid (2×20 mL), saturated NaHCO3 (2×20 mL) and brine (20 mL) and dried over Na2SO4. After
filtration and evaporation of the solvent in vacuo the crude product was purified by column
chromatography or by crystallization.
N'-({2-[(4-Cyanobenzyl)oxy]phenyl}methylidene)-2-naphthalenesulfonohydrazide (5a). Yield 64%;
1
colourless solid; crystallized from ethanol-water; m.p. 147-150 °C. H-NMR: δ 5.12 (s, 2H, Ar-CH2),
6.77-6.87 (m, 2H, Ar-H), 7.19-7.27 (m, 1H, Ar-H), 7.44-7.51 (m, 1H, Ar-H), 7.55-7.81 (m, 2H, Ar-H),
7.68-7.80 (m, 2H, Ar-H), 7.84-7.97 (m, 4H, Ar-H), 8.05-8.11 (m, 1H, Ar-H), 8.18-8.27 (m, 2H, Ar-H),
13
8.66-8.71 (m, 1H, Ar-CH=), 10.17 (s, 1H, CONHN=) ppm; C-NMR (DMSO-d6): δ 156.6, 145.3,
141.4, 134.6, 133.5, 132.6, 131.7, 131.6, 129.5, 129.3, 129.3, 127.7, 127.7, 122.5, 119.3, 118.8, 118.5,
116.2, 110.3 ppm; MS (FAB+) m/z (%): 442 (MH+, 52), 154 (100); IR (KBr): ν 3077, 2226, 1609,
1485, 1348, 1267, 1159, 1046, 899, 759, 656 cm-1; Anal. calc. for C25H19N3O3S: C 68.01, H 4.34, N
9.52%. Found: C 68.24, H 4.32, N 9.54%.

Molecules 2008, 13
24
N'-({2-[(2-Nnitrobenzyl)oxy]phenyl}methylidene)-2-naphthalenesulfonohydrazide (5b). Yield 69%;
1
yellow solid; crystalized from Et2O; m.p. 174-179 °C. H-NMR: δ 5.47 (s, 2H, Ar-CH2-), 6.94-7.02
(dd, J1 = 7.5 Hz, J2 = 7.5 Hz, 1H, Ar-H), 7.00-7.10 (m, 1H, Ar-H), 7.30-7.40 (m, 1H, Ar-H), 7.59-7.75
(m, 5H, Ar-H), 7.77-7.82 (m, 2H, Ar-H), 7.84-7.91 (m, 1H, Ar-H), 7.99-8.05 (d, J = 7.5 Hz, 1H, Ar-
H), 8.09-8.23 (m, 3H, Ar-H), 8.29 (s, 1H, Ar-H), 8.56 (s, 1H, Ar-CH=), 11.60 (s, 1H, Ar-H) ppm; 13C-
NMR: δ 155.9, 147.1, 142.5, 136.1, 134.2, 133.9, 132.0, 131.6, 131.5, 129.1, 129.1, 129.0, 128.8,
128.3, 127.7, 127.4, 125.5, 124.7, 122.4, 121.9, 121.2, 112.9, 66.7 ppm; MS (FAB+): m/z (%): 462
(MH+, 17), 154 (100); IR (KBr): ν 3491, 3225, 1603, 1519, 1329, 1246, 1159, 1049, 954, 745, 659,
544 cm-1; Anal. calc. for C24H19N3O5S: C 62.46, H 4.15, N 9.11%. Found: C 62.62, H 4.20, N 9.05 %.
N'-({2-[(3-Nitrobenzyl)oxy]phenyl}methylidene)-2-naphthalenesulfonohydrazide (5c). Yield 80%; Rf
1
= 0.10 (hexane-ethyl acetate = 1:1); colourless solid; m.p. 133-134 °C. H-NMR: δ 5.18 (s, 2H, Ar-
CH2), 6.79-6.86 (m, 2H, Ar-H), 7.18-7.27 (dd, J1 = 7.7 Hz, J2 = 7.7 Hz, 1H, Ar-H), 7.45-7.53 (d, J =
7.9 Hz, 1H, Ar-H), 7.65-7.81 (m, 3H, Ar-H), 7.81-7.89 (d, J = 7.9 Hz, 1H, Ar-H), 7.91-7.98 (m, 1H,
Ar-H), 8.02 (s, 1H, Ar-H), 8.06-8.12 (d, J = 7.7 Hz, 1H, Ar-H), 8.14-8.27 (m, 4H, Ar-H), 8.70 (s, 1H,
Ar-CH=), 10.18 (s, 1H, SO2NHN) ppm; MS (FAB+): m/z (%): 462 (MH+, 58), 154 (100); IR (KBr): ν
3058, 1621, 1534, 1350, 1266, 1171, 1073, 915, 815, 755, 661, 545 cm-1; Anal. calc. for C24H19N3O5S:
C 62.46, H 4.15, N 9.11%. Found: C 63.09, H 4.26, N 9.00%.
N'-({3-[(3-Nitrobenzyl)oxy]phenyl}methylidene)-2-naphthalenesulfonohydrazide (5d). Yield 80%;
1
yellow solid; crystallized from Et2O; m.p. 156-158 °C. H-NMR: δ 5.14 (s, 2H, Ar-CH2), 6.95-7.01
(m, 1H, Ar-H), 7.11-7.16 (m, 1H, Ar-H), 7.22-7.32 (m, 1H, Ar-H), 7.52-7.69 (m, 3H, Ar-H), 7.71-7.79
(m, 2H, Ar-H), 7.85-8.01 (m, 5H, Ar-H), 8.17-8.22 (m, 1H, Ar-H), 8.31 (s, 1H, Ar-H), 8.58 (s, 1H, Ar-
13
CH=) ppm; C-NMR: δ 158.0, 147.7, 146.8, 139.1, 135.9, 135.0, 134.3, 133.8, 131.6, 129.9, 129.8,
129.1, 128.8, 128.4, 127.7, 127.4, 122.5, 122.4, 121.8, 119.8, 116.6, 112.4, 67.8 ppm; MS (FAB+) m/z
(%): 462 (MH+, 4), 55 (100); IR (KBr): ν 3226, 1574, 1524, 1354, 1354, 1299, 1164, 1063, 977, 823,
756, 671 cm-1; Anal. calc. for C24H19N3O5S: C 62.46, H 4.15, N 9.11%. Found: C 62.58, H 4.19, N
9.05%.
N'-({2-[(4-Cyanobenzyl)oxy]phenyl}methylidene)-2-nitrobenzenesulfonohydrazide (5e). Yield 75%;
1
yellow solid; crystalized from Et2O; m.p. 207-210 °C; H-NMR: δ 5.29 (s, 2H, Ar-CH2-O), 6.99 (m,
1H, Ar-H), 7.15 (m, 1H, Ar-H), 7.37-7.42 (m, 1H, Ar-H), 7.63-7.69 (m, 3H, Ar-H), 7.87-7.91 (m, 4H,
13
Ar-H), 7.99-8.07 (m, 2H, Ar-H), 8.50 (s, 1H, CH=N), 12.08 (s, 1H, NH) ppm; C-NMR DEPT 135:
143.0, 134.4, 132.3, 132.1, 131.6, 130.3, 127.7, 125.3, 124.2, 121.0, 112.9, 68.5 ppm; MS (FAB+) m/z
(%): 437 (MH+, 35), 154 (100); IR (KBr): ν 3235, 2232, 1599, 1524, 1452, 1371, 1240, 1173, 1032,
953, 758, 658, 589 cm-1; Anal. calc. for C21H16N4O5S: C 57.79, H 3.70, N 12.84%. Found: C 57.67, H
3.64, N 12.98%.
N'-({2-[(4-Cyanobenzyl)oxy]phenyl}methylidene)-3-nitrobenzenesulfonohydrazide (5f). Yield 80%;
yellow solid; recrystallized from Et2O; m.p. 185-187 °C. 1H-NMR: δ 5.26 (s, 2H, Ar-CH2-O), 7.00 (m,
1H, Ar-H), 7.13 (m, 1H, Ar-H), 7.36-7.42 (m, 1H, Ar-H), 7.63-7.68 (m, 3H, Ar-H), 7.86-7.96 (m, 3H,
Ar-H), 8.28-8.31 (m, 1H, Ar-H), 8.35 (s, 1H, CH=N), 8.49 (m, 1H, Ar-H), 8.58 (m, 1H, Ar-H), 11.79

Molecules 2008, 13
25
(s, 1H, NH) ppm; 13C-NMR DEPT 135: 143.6, 132.8, 132.0, 131.5, 131.0, 127.6, 127.3, 125.2, 121.5,
120.9, 112.7 ppm; MS (FAB+): m/z (%): 437 (MH+, 25), 55 (100); IR (KBr): ν 3222, 3091, 2233,
1603, 1531, 1340, 1174, 1052, 817, 759, 668 cm-1; Anal. calc. for C21H16N4O5S: C 57.79, H 3.70, N
12.84%. Found: C 57.95, H 3.45, N 12.63%.
N'-({2-[(4-Cyanobenzyl)oxy]phenyl}methylidene)(phenyl)methanesulfonohydrazide (5g). Yield 71%;
colourless solid; recrystallized from Et2O; m.p. 175-177 °C; 1H-NMR: δ 4.56 (s, 2H, Ar-CH2-O), 5.32
(s, 2H, Ar-CH2-SO2), 7.06 (m, 1H, Ar-H), 7.19 (m, 1H, Ar-H), 7.31-7.45 (m, 6H, Ar-H), 7.69 (d, 2H, J
= 8.1 Hz, Ar-H), 7.84 (m, 1H, Ar-H), 7.89 (d, 2H, J = 8.1 Hz, Ar-H), 8.40 (s, 1H, CH=N), 11.25 (s,
1H, NH) ppm; MS (FAB+) m/z (%): 406 (MH+, 55), 154 (100); IR (KBr): ν 3147, 2229, 1602, 1449,
1327, 1251, 1048, 953, 821, 695, 540 cm-1; Anal. calc. for C22H19N3O3S: C 65.17, H 4.72, N 10.36%.
Found: C 65.12, H 4.90, N 10.38%.
N'-({2-[(4-Cyanobenzyl)oxy]phenyl}methylidene)(2-fluorophenyl)methanesulfonohydrazide
(5h).
1
Yield 75%; yellow solid; recrystallized from Et2O; m.p.; 179-181 °C; H-NMR: δ 4.59 (s, 2H, Ar-
CH2-O), 5.32 (s, 2H, Ar-CH2-SO2), 7.05 (m, 1H, Ar-H), 7.12-7.24 (m, 3H, Ar-H), 7.42 (m, 3H, Ar-H),
7,69 (d, 2H, J = 8.0 Hz, Ar-H), 7.77 (m, 1H, Ar-H), 7.89 (d, 2H, J = 8.0 Hz, Ar-H), 8.40 (s, 1H,
CH=N), 11.35 (s, 1H, NH) ppm; 13C-NMR DEPT 135: 141.6, 132.9, 132.8, 132.0, 131.1, 130.3, 130.2,
127.5, 125.5, 124.1, 124.0, 120.9, 115.3, 115.0, 112.7, 68.3, 49.3, 49.3 ppm; MS (FAB+) m/z (%): 424
(MH+, 40), 154 (100); IR (KBr): ν 3151, 2226, 1600, 1451, 1324, 1246, 1045, 955, 757, 555 cm-1;
Anal. calc. for C22H18FN3O3S: C 62.40, H 4.28, N 9.92%. Found: C 62.44, H 4.39, N 9.88%.
N'-({2-[(4-Cyanobenzyl)oxy]phenyl}methylidene)[4-(trifluoromethyl)phenyl]methanesulfonohydrazide
(5i). Yield 79%; colourless solid; recrystallized from Et2O; m.p. 190-192 °C; 1H-NMR: δ 4.72 (s, 2H,
Ar-CH2-O), 5.31 (s, 2H, Ar-CH2-SO2), 7.04 (m, 1H, Ar-H), 7.18 (d, 1H, J = 8.5 Hz, Ar-H), 7.40-7.46
(m, 1H, Ar-H), 7.56 (m, 2H, Ar-H), 7.67-7.79 (m, 6H, Ar-H), 7.88 (d, 2H, J = 8.5 Hz, Ar-H), 8.38 (s,
13
1H, CH=N), 11.30 (s, 1H, NH) ppm; C-NMR DEPT 135: 141.8, 132.0, 131.4, 131.1, 127.5, 125.6,
124.9, 124.8, 120.8, 112.7, 68.4, 55.4 ppm; MS (FAB+): m/z (%): 474 (MH+, 25), 154 (100); IR (KBr):
ν 3191, 2226, 1605, 1452, 1325, 1158, 960, 849, 755, 647 cm-1; Anal. calc. for C23H18N3O3SF3: C
58.35 H 3.83, N 8.87%. Found: C 58.44, H 4.07, N 8.80 %.
2-{[2-(2-Naphthylsulfonyl)hydrazono}methyl]phenyl 2-nitrobenzenesulfonate (7a). Yield 46%; yellow
1
solid; recrystallized from Et2O; m.p. 68-70 °C; H-NMR: δ 7.03-7.10 (m, 1H, Ar-H), 7.33-7.48 (m,
2H, Ar-H), 7.66-8.10 (m, 9H, Ar-H), 8.10-8.27 (m, 3H, Ar-H), 8.55 (s, 1H, Ar-CH=), 11.88 (s, 1H,
13
SO2NHN) ppm; C-NMR: δ 147.7, 146.8, 139.9, 137.0, 135.9, 134.3, 133.0, 131.6, 131.5, 131.4,
129.2, 129.2, 128.9, 128.2, 128.2, 127.7, 127.6, 127.0, 126.3, 125.9, 125.7, 122.7, 122.3 ppm; MS
(FAB+) m/z (%): 512 (MH+, 45), 154 (100); IR (KBr): ν 3197, 1545, 1364, 1163, 869, 778, 658 cm-1;
Anal. calc. for C23H17N3O7S2: C 54.01, H 3.35; N 8.21%. Found: C 54.18, H 3.54, N 7.95 %.
2-{[2-(2-Naphthylsulfonyl)hydrazono}methyl]phenyl 3-nitrobenzenesulfonate (7b). Yield 46%; yellow
solid; m.p. 145-148 °C; 1H-NMR: δ 7.11-7.18 (m, 1H, Ar-H), 7.32-7.49 (m, 2H, Ar-H), 7.65-7.75 (m,
3H, Ar-H), 7.77-7.88 (m, 3H, Ar-H), 8.03-8.09 (m, 1H, Ar-H), 8.10-8.19 (m, 2H, Ar-H), 8.19-8.25 (m,

Molecules 2008, 13
26
1H, Ar-H), 8.35-8.45 (m, 2H, Ar-H), 8.55 (s, 1H, Ar-CH=), 11.79 (s, 1H, SO2NHN=) ppm; 13C-NMR:
δ 147.9, 146.6, 139.6, 135.8, 134.8, 134.3, 133.9, 131.6, 131.6, 131.4, 129.5, 129.2, 129.2, 128.9,
128.2, 128.2, 127.7, 127.6, 126.8, 126.2, 122.9, 122.9, 122.3 ppm; MS (FAB+) m/z (%): 512 (MH+,
23), 154 (100); IR (KBr): ν 3165, 2897, 1604, 1527, 1448, 1329, 1194, 1060, 971, 893, 779, 658, 582
cm-1; Anal. calc. for C23H17N3O7S2: C 54.01, H 3.35; N 8.21%. Found: C 54.24, H 3.47, N 8.19 %.
2-{[2-(2-Naphthylsulfonyl)hydrazono}methyl]phenyl 4-nitrobenzenesulfonate (7c). Yield 80%; yellow
solid; recrystallized from Et2O; m.p. 145-148 °C; 1H-NMR: δ 7.03-7.09 (m, 1H, Ar-H), 7.31-7.39 (m,
1H, Ar-H), 7.39-7.46 (m, 1H, Ar-H), 7.63-7.75 (m, 3H, Ar-H), 7.81-7.87 (m, 1H, Ar-H), 7.90 (s, 1H,
Ar-H), 8.00-8.06 (m, 1H, Ar-H), 8.06-8.16 (m, 3H, Ar-H), 8.18-8.24 (m, 1H, Ar-H), 8.40-8.45 (m, 2H,
13
Ar-H), 8.55 (s, 1H, Ar-CH=N), 11.80 (s, 1H, SO2NHN=) ppm; C-NMR: δ 151.0, 146.6, 139.9,
138.9, 135.8, 134.3, 131.6, 131.4, 129.9, 129.2, 129.1, 128.9, 128.3, 128.1, 127.7, 127.5, 126.9, 126.4,
124.9, 122.7, 122.3 ppm; MS (FAB+) m/z (%): 512 (MH+, 19), 57 (100); IR (KBr): ν 3203, 1603,
1531, 1358, 1162, 1061, 959, 877, 761 cm-1; Anal. calc. for C23H17N3O7S2: C 54.01, H 3.35, N 8.21%.
Found: C 54.29, H 3.52, N 8.02 %.
N-(4-{[2-(2-Naphthylsulfonyl)hydrazono]methyl}phenyl)benzamide (11a). Yield 83%; yellow solid;
1
recrystallized from Et2O; m.p. 197-200 °C; H-NMR: δ 7.50–7.62 (m, 5H, Ar-H), 7.47-6.67 (m, 7H,
Ar-H), 7.89-7.98 (m, 3H, Ar-H), 8.31-8.36 (m, 1H, Ar-H), 8.40 (s, 1H, CH=N-NH), 10.40 (s, 1H, NH-
CO), 11.57 (s, 1H, =N-NH-SO2) ppm; MS (FAB+) m/z (%): 430 (MH+, 86), 55 (100); IR (KBr): ν
3339, 3221, 1652, 1580, 1520, 1410, 1320, 1167, 1049, 957, 830, 748, 665, 549 cm-1; Anal. calc. for
C24H19N3O3S×3/5H20: C 62.73, H 4.40, N 9.14%. Found C 62.71, H 4.27, N 9.18 %.
N-(4-{[2-(2-Naphthylsulfonyl)hydrazono]methyl}phenyl)-3,5-dinitrobenzamide (11b). Yield 72%;
yellow solid; recrystallized from Et2O; m.p. 220-222 °C; 1H-NMR: δ 7.61-7.84 (AA’BB’, J = 8.0 Hz,
Δν = 64.0 Hz, 4H, Ar-H), 7.70 (m, 2H, Ar-H), 7.91-7.93 (m, 2H, Ar-H), 8.03 (d, 1H, J = 8.0 Hz, Ar-
H), 8.15 (m, 1H, Ar-H), 8.23 (d, 1H, J = 8.0 Hz, Ar-H), 8.58 (s, 1H, CH=N-NH), 9.00 (t, 1H, J = 2.0
13
Hz, Ar-H), 9.15 (m, 2H, Ar-H), 10.95 (s, 1H, NH-CO), 11.55 (s, 1H, =N-NH-SO2) ppm; C-NMR
DEPT 135: 146.4, 128.9, 128.9, 128.6, 128.1, 127.7, 127.5, 127.3, 127.1, 122.3, 120.8, 120.2 ppm; MS
(FAB+) m/z (%): 520 (MH+, 64), 154 (100); IR (KBr): ν 3329, 1674, 1531, 1411, 1341, 1164, 832, 717
cm-1; Anal. calc. for C24H17N5O7S×1/3H2O: C 54.85, H 3.39, N 13.33%. Found: C 54.85, H 3.46, N
13.02%.
4-Cyano- N-(4-{[2-(2-naphthylsulfonyl)hydrazono]methyl}phenyl)benzamide (11c). Yield 30%;
1
yellow solid; recrystallized from Et2O; m.p. 201-204 °C; H-NMR: δ 7.55 – 7.81 (AA’BB’, J = 9.0
Hz, Δν = 70.0 Hz, 4H, Ar-H) 7.65-7.74 (m, 2H, Ar-H), 7.89-7.92 (m, 2H, Ar-H), 8.00-8.16 (m, 6H,
Ar-H), 8.21-8.24 (m, 1H, Ar-H), 8.58 (s, 1H, CH=N-NH), 10.60 (s, 1H, NH-CO), 11.53 (s, 1H, =N-
NH-SO2) ppm; MS (FAB+) m/z (%): 455 (MH+, 41), 154 (100); IR (KBr): ν 3342, 3097, 2229, 1654,
1608, 1526, 1414, 1324, 1164, 1054, 961, 637 cm-1; Anal. calc. for C25H18N4O3S×2/3 H2O: C 64.36, H
4.18, N 12.01 %. Found: C 64.17, H 4.06, N 11.85 %.

Molecules 2008, 13
27
N-(4-{[2-(2-Naphthylsulfonyl)hydrazono]methyl}phenyl)-2-nitrobenzamide (11d). Yield 15%; yellow
1
solid; recrystallized from ethanol; m.p. 218-220 °C. H-NMR: δ 7.55-7.58 (m, 2H, Ar-H), 7.67–7.78
(m, 6H, Ar-H), 7.85–7.92 (m, 3H, Ar-H), 8.02-8.24 (m, 4H, Ar-H), 8.58 (s, 1H, CH=N), 10.80 (s, 1H,
13
NH-CO), 11.51 (s, 1H, =N-NH-SO2) ppm; C-NMR DEPT 135: 146.6, 133.8, 130.7, 128.9, 128.8,
128.6, 128.0, 127.5, 127.3, 127.2, 123.9, 122.3, 119.2 ppm; MS (FAB+) m/z (%): 475 (MH+, 65), 154
(100); IR (KBr): ν 3334, 3090, 1658, 1524, 1326, 1164, 961, 744, 658 cm-1; Anal. calc. for
C24H18N4O5S: C 60.75, H 3.82, N 11.81%. Found: C 60.99, H 3.86, N 11.89%.
N-(4-{[2-(2-Naphthylsulfonyl)hydrazono]methyl}phenyl)-4-nitrobenzamide (11e). Yield 24%; yellow
solid; recrystallized from ethanol-water; m.p. 244-247 °C; 1H-NMR: δ 7.58-7.80 (AA’BB’, J = 9.0 Hz,
Δν = 70.0, 4H, Ar-H), 7.69 (m, 2H, Ar-H), 7.91 (m, 2H, Ar-H), 8.03 (m, 1H, Ar-H), 8.13–8.24 (m, 4H,
Ar-H), 8.36 (m, 2H, Ar-H), 8.59 (s, 1H, CH=N), 10.68 (s, 1H, NH-CO), 11.54 (s, 1H, =N-NH-SO2)
13
ppm; C-NMR: 163.9, 149.1, 146.8, 140.2, 140.2, 136.0, 134.2, 131.6, 129.4, 129.2, 129.1, 129.1,
128.9, 128.3, 127.7, 127.5, 127.3, 123.4, 122.5, 120.2 ppm; MS (FAB+) m/z (%): 475 (MH+, 53), 154
(100); IR (KBr): ν 3338, 3080, 1659, 1601, 1525, 1323, 1162, 1055, 829, 689 cm-1; Anal. calc. for
C24H18N4O5S: C 60.75, H 3.82, N 11.81%. Found: C 60.23, H 3.96, N 11.46%.
3-Bromo-N-(4-{[2-(2-naphthylsulfonyl)hydrazono]methyl}phenyl)benzamide (11f). Yield 20%; yellow
solid; recrystallized from Et2O; m.p. 227-230 °C; 1H-NMR: δ 7.38–7.55 (m, 5H, Ar-H), 7.66–7.73 (m,
5H, Ar-H), 7.89 (m, 2H, Ar-H), 8.02 (d, 1H, J = 8.0 Hz, Ar-H), 8.13 (m, 1H, Ar-H), 8.21 (d, 1H, J =
13
8.0 Hz, Ar-H), 8.57 (s, 1H, CH=N), 10,61 (s, 1H, NH-CO), 11.48 (s, 1H, =N-NH-SO2) ppm; C-
NMR: δ 118.8, 119.4, 122.5, 127.4, 127.5, 127.6, 127.6, 127.7, 127.8, 128.3, 128.7, 128.9, 128.9,
129.0, 129.1, 129.2, 131.1, 131.6, 132.6, 132.6, 134.2, 136.0, 138.8, 140.4, 146.9, 165.8 ppm; MS
(FAB+) m/z (%): 508/510 (MH+, 63), 69 (100); IR (KBr): ν 3363, 3160, 1650, 1526, 1332, 1163, 962,
818, 744, 571 cm-1; Anal. calc. for C24H18BrN3O3S: C 56.70, H 3.57, N 8.27%. Calc: C 56.94, H 3.69,
N 8.42%.
2-Bromo-N-(4-{[2-(2-naphthylsulfonyl)hydrazono]methyl}phenyl)benzamide (11g). Yield 38%; yellow
solid; recrystallized from Et2O; m.p. 197-200 °C; 1H-NMR: δ 7.52 (m, 3H, Ar-H), 7.70 (m, 2H, Ar-H),
7.79 (m, 3H, Ar-H), 7.89 – 7.95 (m, 2H, Ar-H), 7.91 (s, 1H, CH=N-NH), 8.03 (d, 1H, J = 8.0 Hz, Ar-
H), 8.12 – 8.16 (m, 2H, Ar-H), 8.23 (d, 1H, J = 8.0 Hz, Ar-H), 8.58 (s, 1H, CH=N), 10.45 (s, 1H, NH-
CO), 11.50 (s, 1H, =N-NH-SO2) ppm; MS (FAB+) m/z (%): 508/510 (MH+, 86), 57 (100); IR (KBr): ν
3207, 1664, 1588, 1521, 1410, 1322, 1165, 1044, 959, 859, 745, 661 cm-1; Anal calc. for
C24H18BrN3O3S: C 56.70, H 3.57, N 8.27 %. Found: C 57.04, H 3.77, N 7.80 %.
N-(4-{[2-(2-Naphthylsulfonyl)hydrazono]methyl}phenyl)-2-naphthamide (11h). Yield 52%; yellow
1
solid; recrystallized from Et2O; m.p. 224-227 °C; H-NMR: δ 7.55 (m, 2H, Ar-H), 7.62–7.71 (m, 4H,
Ar-H), 7.85–7.93 (m, 3H, Ar-H), 7.93 (s, 1H, Ar-H), 8.00–8.15 (m, 6H, Ar-H), 8.22 (m, 1H, Ar-H),
13
8.58 (s, 1H, CH=N), 10.58 (s, 1H, NH-CO), 11.58 (s, 1H, =N-NH-SO2) ppm; C-NMR DEPT 135:
184.2, 166.5, 166.4, 166.4, 166.2, 165.6, 165.6, 165.4, 165.2, 165.1, 165.0, 164.8, 164.5, 164.0, 161.6,
159.9, 157.4 ppm; MS (FAB+) m/z (%): 480 (MH+, 71), 154 (100); IR (KBr): ν 3361, 3055, 1650,

Molecules 2008, 13
28
1520, 1321, 1162, 964, 819, 661 cm-1; Anal. calc. for C28H21N3O3S: C 70.13, H 4.41, N 8.76%. Found:
C 70.23, H 4.21, N 8.90%.
N-(2-{[2-(2-Naphthylsulfonyl)hydrazono]methyl}phenyl)-3,5-dinitrobenzamide (11i). Yield 84%;
yellow solid; crystallized from ethyl acetate; m.p. 214-217 °C; 1H-NMR: δ 7.30 (dd, 1H, J1 = J2 = 7.5
Hz, Ar-H), 7.47 (dd, 1H, J1 = J2 = 7.5 Hz, Ar-H), 7.62 – 7.78 (m, 5H, Ar-H), 7.99 – 8.10 (m, 4H, Ar-
H), 8.33 (s, 1H, CH=N), 9.02 (t, 1H, J = 2.0 Hz, Ar-H), 9.07-9.07 (m, 2H, Ar-H), 11.19 (s, 1H, NH-
CO), 11.74 (s, 1H, =N-NH-SO2) ppm; MS (FAB+) m/z (%): 520 (MH+, 58), 154 (100); IR (KBr): ν
3239, 3099, 1666, 1582, 1532, 1432, 1349, 1162, 961, 724, 662 cm-1; Anal. calc. for
C24H17N5O7S×1/3H2O: C 54.85, H 3.39, N 13.33%. Found: C 54.85, H 3.46; N 13.02%.
N-(2-{[2-(2-Naphthylsulfonyl)hydrazono]methyl}phenyl)-4-nitrobenzamide (11j). Yield 46%; m.p.
195-198 °C; 1H-NMR: δ 7.30 (m, 1H, Ar-H), 7.47 (m, 1H, Ar-H), 7.62 – 7.78 (m, 5H, Ar-H), 7.99 (m,
1H, Ar-H), 8,08 (m, 2H, Ar-H), 8.10 (s, 1H, Ar-H,), 8.33 (s, 1H, CH=N), 9.05 (dd, 3H, J1 = 12.5 Hz, J2
= 2.0 Hz, Ar-H), 11.19 (s, 1H, NH-CO), 11.74 (s, 1H, =N-NH-SO2) ppm; MS (FAB+) m/z (%): 475
(MH+, 32), 154 (100); IR (KBr): ν 3314, 2973, 1657, 1553, 1507, 1409, 1362, 1147, 958, 729 cm-1;
Anal. calc. for C24H18N4O5S×1/2H2O: C 59.62, H 3.96, N 11.59%. Found: C 59.47, H 4.13; N 11.48%.
2-{[2-(Naphthalen-2-ylsulfonyl)hydrazono]methyl}phenyl 2-(benzo[d][1,3]dioxol-5-yl)acetate (14).
Yield 90%; yellow solid; Rf = 0.10 (hexane-ethyl acetate = 4:1); m.p. 175-176 °C; 1H-NMR: δ 3.93 (s,
2H, CH2-COO), 6.01 (s, 2H, O-CH2-O), 6.78-6.91 (m, 2H, Ar-H), 6.92-6.95 (m, 1H, Ar-H), 7.08-7.15
(m, 1H, Ar-H), 7.23-7.31 (m, 1H, Ar-H), 7.37-7.45 (m, 1H, Ar-H), 7.60-7.75 (m, 3H, Ar-H), 7.84-7.90
(m, 1H, Ar-H), 7.07 (s, 1H, Ar-H), 8.00-8.06 (m, 1H, Ar-H), 8.10-8.20 (m, 2H, Ar-H), 8.53 (s, 1H, Ar-
13
CH=), 11.70 (s, 1H, SO2NHN=) ppm; C-NMR: δ 170.0, 148.5, 147.2, 146.2, 142.6, 135.9, 134.3,
131.6, 131.0, 129.2, 129.1, 128.9, 128.3, 127.7, 127.5, 127.2, 127.0, 126.3, 125.7, 123.2, 122.7, 122.3,
109.9, 108.0, 100.8 ppm; MS (FAB+) m/z (%): 489 (MH+, 3), 154 (100); IR (KBr): ν 3427.2, 3213.5,
1755.3, 1506.5, 1505.4, 1450.3, 1333.9, 1257.4, 1131.2, 1042.0, 933.8, 820.0, 660.9 cm-1; Anal. calc.
for C26H20N2O6S: C 63.93, H 4.13, N, 5.73. Found: C 62.62, H 4.20, N 5.79.
Enzyme assays
The compounds were tested for their ability to inhibit the addition of L-Ala (D-Glu) to UDP-
MurNAc (UDP-MurNAc-L-Ala) catalyzed by MurC (MurD) from E. coli [23, 24]. Detection of
orthophosphate generated during the reaction was based on the colorimetric Malachite green method
as described elsewhere [25], with slight modification. Mixtures (final volume: 50 μL) contained 50
mM Hepes, pH 8.0, 3.25 mM MgCl2, 120 μM UDP-MurNAc (80 μM UDP-MurNAc-L-Ala), 120 μM
L-Ala (100 μM D-Glu), 450 μM ATP (400 μM ATP), purified MurC (MurD) (diluted with 20 mM
Hepes, pH 7.2, 1 mM dithiothreitol) and 100 µM of tested compound dissolved in DMSO. In all cases,
the final concentration of DMSO was 5% (v/v). Compounds that were not soluble in the enzyme assay
mixture were tested in concentrations lower than 100 µM. The reaction mixtures were incubated at
37°C for 15 min, then quenched with Biomol® reagent (100 µL) and the absorbance at 650 nm
measured after 5 min. The residual activity was calculated with respect to a similar assay with DMSO

Molecules 2008, 13
29
and without inhibitor. IC50 constants were determined by measuring residual activity at seven different
inhibitor concentrations; values ± standard deviations at 95% of confidence were calculated from the
fitted regression equations using the logit-log plot.
Acknowledgements
This work was supported by the European Union FP6 Integrated Project EUR-INTAFAR (Project
No. LSHM-CT-2004-512138) under the thematic priority of Life Sciences, Genomics and
Biotechnology for Health. The support from the Ministry of Higher Education, Science and
Technology of the Republic of Slovenia and the Slovenian Research Agency is also acknowledged.
We also thank Professor R. Pain for reading the manuscript.
References
1. Hiramatsu, K.; Okuma, K.; Ma, X.X.; Yamamoto, M.; Hori, S.; Kapi, M. New trends in
Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in
the community. Curr. Opin. Infect. Dis. 2002, 15, 407-413.
2. Herrero, I.A.; Issa, N.C; Patel R. Nosocomial spread of linezolid-resistant, vancomycin-resistant
Enterococcus faecium. N. Engl. J. Med. 2002, 346, 867-869.
3. Jana, S.; Deb, J.K. Molecular targets for design of novel inhibitors to circumvent aminoglycoside
resistance. Curr. Drug Targ. 2005, 6, 353-361.
4. van Heijenoort, J. Recent advances in the formation of the bacterial peptidoglycan monomer unit.
Nat. Prod. Rep. 2001, 18, 503–519.
5. El Zoeiby, A.; Sanschagrin, F.; Levesque, R.C. Structure and function of the Mur enzymes:
development of novel inhibitors. Mol. Microbiol. 2003, 47, 1-12.
6. Mengin-Lecreulx, D.; Flouret, B.; van Heijenoort, J. Cytoplasmic steps of peptidoglycan synthesis
in Escherichia coli. J. Bacteriol. 1982, 151, 1109-1117.
7. Sim, M.M.; Ng, S.B.; Buss, A.D.; Crasta, S.C.; Goh, K.L.; Lee, S.K. Benzylidene rhodanines as
novel inhibitors of UDP-N-acetylmuramate/L-alanine ligase. Bioorg. Med. Chem. Lett. 2002, 12,
697-699.
8. Cukurovali, A.; Yilmaz, I.; Gur, S.; Kazaz, C. Synthesis, antibacterial and antifungal activity of
some new thiazolylhydrazone derivatives containing 3-substituted cyclobutane ring. Eur. J. Med.
Chem. 2006, 41, 201-207.
9. Ersan, S.; Nacak, S.; Berkem, R. Synthesis and antimicrobial activity of N-[(alpha-
methyl)benzylidene]-(3-substituted-1,2,4-triazol-5-yl-thio) acetohydrazides. Farmaco 1998, 53,
773-776.
10. El-Gaby, M.S.A.; Atalla, A.A.; Gaber, A.M.; Abd Al-Wahab K.A. Studies on aminopyrazoles:
antibacterial activity of some novel pyrazoles. Farmaco 2000, 55, 596-602.
11. Rollas, S., Gulerman, N.; Erdeniz, H. Synthesis and antimicrobial activity of some new
hydrazones of 4-fluorobenzoic acid hydrazide and 3-acetyl-2,5-disubstituted-1,3,4-oxadiazolines.
Farmaco 2002, 57, 171-174.

Molecules 2008, 13
30
12. Vicini, P.; Zani, F.; Cozzini, P; Doytchinova, I. Hydrazones of 1,2-benzisothiazole hydrazides:
synthesis, antimicrobial activity and QSAR investigations. Eur. J. Med. Chem. 2002, 37, 553-564.
13. Islam, A.M.; Abdel-Halim, A.M.; Salama, M.A. Synthesis of some naphthalene
sulfonohydrazides and related compounds of potential biological activity. Egypt. J. Chem. 1987,
29, 405-431.
14. Guibé-Jampel, E.; Wakselman, M. p-Nitrobenzyl side-chain protection for solid-phase synthesis.
Synth. Commun. 1982, 12, 219-223.
15. Wu, X.; Hu, L. Amide bond formation from selenocarboxylates and aromatic azides. Tetrahedron
Lett. 2005, 46, 8401-8405.
16. Folkes, A.; Roe, M.B.; Sohal, S.; Golec, J.; Faint, R.; Brooks, T.; Charlton, P. Synthesis and in
vitro evaluation of a series of diketopiperazine inhibitors of plasminogen activator inhibitor-1.
Bioorg. Med. Chem. Lett. 2001, 11, 2589–2592.
17. Feng, B.Y.; Shelat, A.; Doman, T.N.; Guy, R.K.; Shoichet, B.K.: High-throughput assays for
promiscuous inhibitors. Nat. Chem. Biol. 2005, 1, 146-148.
18. Wagner, G.; Eppner, B. Synthesis of 2-(4-amidinophenyl)-benzofuran, -benzoxazole
and -benzothiazole as well as of 2-(4-amidinobenzyl)benzoxazole. Pharmazie 1980, 35, 285-288.
19. Mukkala, V.M.; Helenius, M.; Hemmila, I.; Kankare, J.; Takalo, H. Development of luminescent
europium(III) and terbium(III) chelates of 2,2':6',2''-terpyridine derivatives for protein labeling.
Helv. Chim. Acta 1993, 76, 1361-1378.
20. Sanders, G.M.; Van Dijk, M.; Van Veldhuizen, A.; Van der Plas, H.C.; Hofstra, U.; Schaafsma,
T.J. Studies on the conformation of 5,15-diarylporphyrins with (arylsulfonyl)oxy substituents. J.
Org. Chem. 1988, 53, 5272-5281.
21. Morgenstern, O.; Richter, P. Synthesis and reactivity of 3-methyl-2-thioxo-1,2-dihydro-3H-1,3,4-
benzotriazepine. Wissen. Z. Ernst-Moritz-Arndt-Univ. Greifswald, Math.-Nat. 1988, 37, 34-37.
22. Flamigni, L.; Ventura, B.; Tasior, M.; Gryko, D.T. Photophysical properties of a new, stable
corrole-porphyrin dyad. Inorg. Chim. Acta 2007, 360, 803-813.
23. Liger, D.; Masson, A.; Blanot, D.; van Heijenoort, J.; Parquet, C. Over-production, purification
and properties of the uridine-diphosphate-N-acetylmuramate:L-alanine ligase from Escherichia
coli. Eur. J. Biochem. 1995, 230, 80-87.
24. Auger, G.; Martin, L.; Bertrand, J.; Ferrari, P.; Fanchon, E.; Vaganay, S.; Pétillot, Y.; van
Heijenoort, J.; Blanot, D.; Dideberg, O. Large-scale preparation, purification, and crystallization
of UDP-N-acetylmuramoyl-L-alanine: D-glutamate ligase from Escherichia coli. Prot. Express.
Purif. 1998, 13, 23-29.
25. Lanzetta, P.A.; Alvarez, L.J.; Reinach, P.S.; Candia, O. An improved assay for nanomole amounts
of inorganic phosphate. Anal. Biochem. 1979, 100, 95-97.
Sample Availability: Contact the authors.
© 2008 by MDPI (http://www.mdpi.org). Reproduction is permitted for noncommercial purposes.